米兰会议关于分析性能规范模型定义与检验对象分配的启示
本文总结了2014年欧洲临床化学与检验医学联合会(EFLM)米兰战略会议关于分析性能规范(APS)的核心概念遗产。作者讨论了如何使米兰共识更具实用性,包括各利益相关方的角色与主要行动,以推动APS在临床检验中的实际应用。
要点
- APS是确保检验信息满足临床需求的质量标准。
- 米兰会议提出了APS模型定义与检验对象分配的战略概念。
- 需明确各利益相关方角色以推动APS共识落地。
核心结论
- 米兰会议为APS模型定义与检验对象分配提供了战略框架,需各方协同推进其实用化。
临床怎么用
- 检验科应依据APS共识明确检验项目的质量要求,并推动多角色协作落实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Analytical performance specifications (APS) represent the criteria that specify the quality required for laboratory test information to satisfy clinical needs. In 2014 the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) considered timely to update the topic of APS by organizing a conference in Milan in which some strategic concepts were proposed. Here I summarize the essential points representing the EFLM Strategic Conference heritage and discuss the approaches that will permit us to become more concrete, including roles and main actions expected from each of involved stakeholders for contributing a quantum leap forward in the way of practicality of Milan consensus about APS.
引用
- Panteghini M. What the Milan conference has taught us about analytical performance specification model definition and measurand allocation. Clin Chem Lab Med. 2024. PMID: 38277658. doi:10.1515/cclm-2023-1257
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。